Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc > Cash and Short-Term Investments

Apellis Pharmaceuticals Inc Cash and Short-Term Investments Chart (APLS)

Apellis Pharmaceuticals Inc annual/quarterly Cash and Short-Term Investments from 2017 to 2018.
  • Apellis Pharmaceuticals Inc Cash and Short-Term Investments for the quarter ending December 12, 2018 was $176m a 13.24% increase of 23m year over year
  • Apellis Pharmaceuticals Inc Cash and Short-Term Investments for the last 12 months ending December 12, 2018 was $176m a 13.24% increase of 23m year over year
  • Apellis Pharmaceuticals Inc Annual Cash and Short-Term Investments for 2018 was $176m a 0.35% increase of 1m from 2017
  • Apellis Pharmaceuticals Inc Annual Cash and Short-Term Investments for 2017 was $176m a 85.84% increase of 151m from 2016
  • Apellis Pharmaceuticals Inc Annual Cash and Short-Term Investments for 2016 was $25m a -44.80% decrease of -11m from 2015
Other Balance Sheet Metrics:
  • Apellis Pharmaceuticals Inc Total Assets for the quarter ending September 09, 2018 was $239m a 23.84% increase of 57m year over year
  • Apellis Pharmaceuticals Inc Other Liabilities for the quarter ending December 12, 2018 was $0m a -57.45% decrease of 0m year over year
  • Apellis Pharmaceuticals Inc Total Equity for the quarter ending September 09, 2018 was $196m a 23.99% increase of 47m year over year
View Chart On Koyfin

Quarterly APLS Cash and Short-Term Investments Data

12/2018$176m
09/2018$221m
06/2018$254m
03/2018$153m
12/2017$176m
09/2017$13m
06/2017$5m
03/2017$25m

Annual APLS Cash and Short-Term Investments Data

2018$176m
2017$176m
2016$25m
2015$36m